Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs – GlobeNewswire
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs GlobeNewswire
The truth about peptides that social media won’t tell you – Scientific American
The truth about peptides that social media won’t tell you Scientific American
The truth about peptides that social media won’t tell you – Scientific American Read Post »
Creatine’s role in health and wellness grows – SupplySide Supplement Journal
Creatine’s role in health and wellness grows SupplySide Supplement Journal
Creatine’s role in health and wellness grows – SupplySide Supplement Journal Read Post »
The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways.
This groundbreaking study in C. elegans worms demonstrates that GHK-Cu significantly extends lifespan and improves multiple age-related health markers including stress resistance, mobility, and cellular function. The research identified specific molecular mechanisms: GHK-Cu preserves mitochondrial function by increasing membrane potential and promoting cellular energy production, while activating key longevity pathways (DAF-16 and SKN-1) that regulate antioxidant defenses. This is the first study to provide mechanistic evidence for GHK-Cu’s anti-aging effects through coordinated mitochondrial and cellular pathway regulation. The findings establish GHK-Cu as a validated geroprotective compound with defined molecular targets for anti-aging interventions.
Intracellular NAD+ Depletion Increases Prostanoid Production via p38/COX2 Signalling in FK866-Induced Senescent Human Umbilical Vein Endothelial Cells.
This study demonstrates that NAD+ depletion in vascular endothelial cells triggers a senescence-like state that increases production of pro-inflammatory prostanoids (PGF1α and TXB2) via p38 MAPK and COX2 activation. Using FK866 to deplete NAD+, researchers showed this pathway drives vascular dysfunction associated with aging and cardiovascular disease. Crucially, NMN supplementation reversed NAD+ depletion, suppressed the senescence phenotype, and attenuated prostanoid overproduction, suggesting NAD+ restoration as a therapeutic target for age-related vascular pathology.
Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery.
This human tissue study demonstrates that BPC-157 produces concentration-dependent vasodilation in human internal mammary artery rings, with the effect significantly dependent on endothelial nitric oxide (NO) signaling. The research shows BPC-157’s relaxant effect is substantially greater in endothelium-intact tissue and is largely blocked by NOS inhibition, confirming the NO-mediated mechanism in human vascular tissue—a critical gap filled from prior animal-only data. This is the first functional evidence of BPC-157’s vasodilatory mechanism in human arterial tissue, strengthening the scientific foundation for cardiovascular and vascular health claims.
Cuproptosis causes meiotic metaphase I arrest by disrupting mitochondrial functions in oocytes.
This research demonstrates that copper-induced cell death (cuproptosis) impairs female oocyte maturation by disrupting mitochondrial function and energy production. The study found that NMN supplementation—a NAD+ precursor—effectively restores mitochondrial function and partially rescues meiotic arrest in oocytes exposed to copper stress. The findings position NAD+ metabolism as a therapeutic target for protecting egg quality and female fertility, with direct clinical implications for practitioners working with reproductive health.
Extracellular matrix-derived matrikines as emerging modulators of neuroinflammation and central nervous system signaling.
This review identifies matrikines—bioactive peptide fragments derived from extracellular matrix proteins—as a distinct class of neuroimmune modulators with therapeutic potential in neuroinflammation and neurodegeneration. GHK, a collagen-derived matrikine, is highlighted as a CNS-relevant compound that modulates microglial and astrocytic function, enhances neuronal survival, and may cross a compromised blood-brain barrier. The authors emphasize that matrikines represent an emerging therapeutic avenue complementary to classical immune mediators, but call for urgent human tissue studies to establish translational relevance and clinical utility.
Nicotinamide mononucleotide (NMN) improves the ovarian microenvironment associated with oocyte quality by increasing estrogen signaling, reprogramming ovarian metabolism, reducing oxidative stress, and inhibiting apoptosis in the spotted scat (Scatophagus argus).
This animal study in spotted scat fish demonstrated that NMN injections significantly improved ovarian function by increasing NAD+ levels and estrogen production. The treatment enhanced glucose and lipid metabolism, reduced oxidative stress, and improved mitochondrial function in ovarian tissue. Key findings included upregulation of steroidogenesis genes, increased antioxidant capacity, and reduced cellular death pathways, all contributing to better oocyte quality and reproductive health.
Nicotinamide Ameliorates Deoxynivalenol-Induced Injury in Renal Cells via Inhibiting PARP1 Hyperactivation and Restoring NAD+ Homeostasis.
This in vitro study demonstrates that the mycotoxin deoxynivalenol (DON) causes severe renal cell damage primarily through PARP1 hyperactivation and consequent NAD+ depletion, rather than through NAMPT inhibition as previously thought. Nicotinamide (NAM) successfully rescued cells by suppressing PARP1 activity and restoring NAD+ pools, while NMN supplementation alone did not protect against DON toxicity. The findings suggest that NAD+ restoration strategies targeting PARP1 inhibition may offer therapeutic value for mycotoxin exposure, relevant to practitioners considering NAD+-supporting interventions for clients with food safety concerns or oxidative stress conditions.
NAMPT orchestrates fibroblast cuproptosis and immune crosstalk during IPF progression.
This research identifies cuproptosis—a copper-dependent cell death pathway—as a novel mechanism that could regulate fibroblast survival and reduce excessive collagen deposition in idiopathic pulmonary fibrosis (IPF). The study positions NAMPT as a key orchestrator of this process, suggesting that modulating copper-dependent cell death in fibroblasts may offer a therapeutic approach to IPF where current treatments have limited efficacy. GHK-Cu, a copper-peptide complex, directly aligns with cuproptosis biology and may warrant investigation as a potential therapeutic agent in fibrotic disease management.
NAMPT orchestrates fibroblast cuproptosis and immune crosstalk during IPF progression. Read Post »
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.
Researchers evaluated BPC-157 and two newly designed hybrid peptide analogs (CIARA-1 and CIARA-2) as competitive inhibitors of acetylcholinesterase, an enzyme target in Alzheimer’s disease management. All three compounds showed reversible competitive inhibition, with the hybrid analogs demonstrating superior potency compared to native BPC-157. While the peptides are significantly less potent than approved AChE inhibitors, the study validates BPC-157 as a viable scaffold for developing multifunctional neurodegenerative therapeutics through rational structural modification.
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase. Read Post »